keyword
MENU ▼
Read by QxMD icon Read
search

Saccharomyces boulardii

keyword
https://www.readbyqxmd.com/read/28482385/-a-multicenter-randomized-controlled-study-of-saccharomyces-boulardii-in-the-prevention-of-antibiotic-associated-diarrhea-in-infants-and-young-children
#1
C M Wan, H Yu, G Liu, H M Xu, Z Q Mao, Y Xu, Y Jin, R P Luo, W J Wang, F Fang
Objective: To evaluate the efficacy and safety of Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea (AAD) in infants and young children. Method: From November 2012 to September 2013, ten research units of large teaching hospitals or children's hospitals participated in this multicenter randomized controlled clinical trial. Hospitalized young children aged between 1 month and 3 years (nongastrointestinal infection and antibiotic therapy required)were involved in our study. The children were randomly divided into control group and prevention group by means of block random allocation method...
May 4, 2017: Zhonghua Er Ke za Zhi. Chinese Journal of Pediatrics
https://www.readbyqxmd.com/read/28465509/saccharomyces-boulardii-administration-changes-gut-microbiota-and-attenuates-d-galactosamine-induced-liver-injury
#2
Lei Yu, Xue-Ke Zhao, Ming-Liang Cheng, Guo-Zhen Yang, Bi Wang, Hua-Juan Liu, Ya-Xin Hu, Li-Li Zhu, Shuai Zhang, Zi-Wen Xiao, Yong-Mei Liu, Bao-Fang Zhang, Mao Mu
Growing evidence has shown that gut microbiome is a key factor involved in liver health. Therefore, gut microbiota modulation with probiotic bacteria, such as Saccharomyces boulardii, constitutes a promising therapy for hepatosis. In this study, we aimed to investigate the protective effects of S. boulardii on D-Galactosamine-induced liver injury in mice. Liver function test and histopathological analysis both suggested that the liver injury can be effectively attenuated by S. boulardii administration. In the meantime, S...
May 2, 2017: Scientific Reports
https://www.readbyqxmd.com/read/28388647/impact-of-probiotic-saccharomyces-boulardii-on-the-gut-microbiome-composition-in-hiv-treated-patients-a-double-blind-randomised-placebo-controlled-trial
#3
Judit Villar-García, Robert Güerri-Fernández, Andrés Moya, Alicia González, Juan J Hernández, Elisabet Lerma, Ana Guelar, Luisa Sorli, Juan P Horcajada, Alejandro Artacho, Giuseppe D Auria, Hernando Knobel
Dysbalance in gut microbiota has been linked to increased microbial translocation, leading to chronic inflammation in HIV-patients, even under effective HAART. Moreover, microbial translocation is associated with insufficient reconstitution of CD4+T cells, and contributes to the pathogenesis of immunologic non-response. In a double-blind, randomised, placebo-controlled trial, we recently showed that, compared to placebo, 12 weeks treatment with probiotic Saccharomyces boulardii significantly reduced plasma levels of bacterial translocation (Lipopolysaccharide-binding protein or LBP) and systemic inflammation (IL-6) in 44 HIV virologically suppressed patients, half of whom (n = 22) had immunologic non-response to antiretroviral therapy (<270 CD4+Tcells/μL despite long-term suppressed viral load)...
2017: PloS One
https://www.readbyqxmd.com/read/28368269/probiotics-for-feed-tolerance-in-very-low-birth-weight-neonates-a-randomized-controlled-trial
#4
A Shashidhar, P N Suman Rao, Saudamini Nesargi, Swarnarekha Bhat, B S Chandrakala
OBJECTIVE: To measure the efficacy of a probiotic formulation on time to reach full enteral feeds in VLBW (very low birth weight) newborns. DESIGN: A blinded randomized control trial. SETTING: A tertiary care neonatal intensive care unit (NICU) in Southern India between August 2012 to November 2013. PARTICIPANTS: 104 newborns with a birth weight of 750-1499 g on enteral feeds. INTERVENTION: Probiotic group (n=52) received a multicomponent probiotic formulation of Lactobacillus acidophilus, Lactobacillus rhamnosus, Bifidobacterium longum and Saccharomyces boulardii once a day at a dose of 1...
March 29, 2017: Indian Pediatrics
https://www.readbyqxmd.com/read/28339160/biofortification-of-riboflavin-and-folate-in-idli-batter-based-on-fermented-cereal-and-pulse-by-lactococcus-lactis-n8-and-saccharomyces-boulardii-saa655
#5
S C Chandrasekar Rajendran, B Chamlagain, S Kariluoto, V Piironen, P E J Saris
AIMS: Lactococcus lactis N8 and Saccharomyces boulardii SAA655 were investigated for their ability to synthesize B-vitamins (riboflavin and folate) and their functional role as microbial starters in idli fermentation. METHODS AND RESULTS: In this study, ultra-high performance liquid chromatography and microbiological assay were used to determine the total riboflavin and folate content respectively. Increased levels of folate were evident in both L. lactis N8 and S...
March 24, 2017: Journal of Applied Microbiology
https://www.readbyqxmd.com/read/28336969/complete-genome-sequence-and-comparative-genomics-of-the-probiotic-yeast-saccharomyces-boulardii
#6
Indu Khatri, Rajul Tomar, K Ganesan, G S Prasad, Srikrishna Subramanian
The probiotic yeast, Saccharomyces boulardii (Sb) is known to be effective against many gastrointestinal disorders and antibiotic-associated diarrhea. To understand molecular basis of probiotic-properties ascribed to Sb we determined the complete genomes of two strains of Sb i.e. Biocodex and unique28 and the draft genomes for three other Sb strains that are marketed as probiotics in India. We compared these genomes with 145 strains of S. cerevisiae (Sc) to understand genome-level similarities and differences between these yeasts...
March 23, 2017: Scientific Reports
https://www.readbyqxmd.com/read/28333335/saccharomyces-boulardii-cncm-i-745-restores-intestinal-barrier-integrity-by-regulation-of-e-cadherin-recycling
#7
Chloé Terciolo, Aurélie Dobric, Mehdi Ouaissi, Carole Siret, Gilles Breuzard, Françoise Silvy, Bastien Marchiori, Sébastien Germain, Renaté Bonier, Adel Hama, Roisin Owens, Dominique Lombardo, Véronique Rigot, Frédéric André
Background and Aims: Alteration in intestinal permeability is the main factor underlying the pathogenesis of many diseases affecting the gut, such as inflammatory bowel disease (IBD). Characterization of molecules targeting the restoration of intestinal barrier integrity is therefore vital for the development of alternative therapies. The yeast Saccharomyces boulardii CNCM I-745 (Sb), used to prevent and treat antibiotic-associated infectious and functional diarrhea, may have a beneficial effect in the treatment of IBD...
February 22, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28319123/saccharomyces-boulardii-and-bacillus-subtilis-b10-modulate-tlrs-and-cytokines-expression-patterns-in-jejunum-and-ileum-of-broilers
#8
Imran Rashid Rajput, Huang Ying, Sun Yajing, Muhammad Asif Arain, Li Weifen, Li Ping, Dost Muhammad Bloch, Liu Wenhua
The present study was designed to evaluate the effects of Saccharomyces boulardii (Sb) and Bacillus subtilis B10 (Bs) on intestinal epithelial Toll like receptors (TLR), and Cytokine expression response to understand the intestinal epithelial innate immune mechanism in broilers. A total of 300 birds (Sanhuang broilers) were allotted into three groups (n = 100) and each divided into five replications (n = 20). Control group (Ctr) birds were fed basal diet, broilers in experimental groups received (1×108cfu/kg feed) Sb and Bs respectively in addition to basal diet for 72 days...
2017: PloS One
https://www.readbyqxmd.com/read/28294322/probiotics-are-a-good-choice-in-remission-of-inflammatory-bowel-diseases-a-meta-analysis-and-systematic-review
#9
Mahboube Ganji-Arjenaki, Mahmoud Rafieian-Kopaei
Altered gut bacteria and bacterial metabolic pathways are two important factors in initiation and progression of inflammatory bowel disease (IBD). However, efficacy of probiotics in remission of patients with IBD has not been characterized. This study was performed on the studies that specifically assessed the efficacy of probiotics in attaining clinical response on patients with various types of IBD. The efficacy of variant species of probiotics in different conditions and the influence of study quality in outcomes of randomized controlled trials (RCTs) were also assessed...
March 15, 2017: Journal of Cellular Physiology
https://www.readbyqxmd.com/read/28280685/catheter-related-saccharomyces-cerevisiae-fungemia-following-saccharomyces-boulardii-probiotic-treatment-in-a-child-in-intensive-care-unit-and-review-of-the-literature
#10
Serkan Atıcı, Ahmet Soysal, Kıvılcım Karadeniz Cerit, Şerife Yılmaz, Burak Aksu, Gürsu Kıyan, Mustafa Bakır
Although Saccharomyces boulardii is usually a non-pathogenic fungus, in rare occasions it can cause invasive infection in children. We present the case of an 8-year-old patient in pediatric surgical intensive care unit who developed S. cerevisiae fungemia following probiotic treatment containing S. boulardii. Caspofungin was not effective in this case and he was treated with amphotericin B. We want to emphasize that physicians should be careful about probiotic usage in critically ill patients.
March 2017: Medical Mycology Case Reports
https://www.readbyqxmd.com/read/28188340/development-and-validation-of-a-new-dynamic-in-vitro-model-of-the-piglet-colon-pigutivm-application-to-the-study-of-probiotics
#11
Mickaël Alain Fleury, Olivier Le Goff, Sylvain Denis, Frédérique Chaucheyras-Durand, Eric Jouy, Isabelle Kempf, Monique Alric, Stéphanie Blanquet-Diot
For ethical, technical, regulatory, and cost reasons, in vitro methods are increasingly used as an alternative to in vivo experimentations. The aim of the present study was to validate, according to in vivo data in living animals, a new in vitro model of the piglet colon, the PigutIVM, under both control conditions and antibiotic disturbance by the widely used colistin. The PigutIVM reproduces the main biotic and abiotic parameters of the piglet colon: temperature, pH, retention time, supply of ileal effluents, complex, and metabolically active microbiota and self-maintained anaerobiosis...
March 2017: Applied Microbiology and Biotechnology
https://www.readbyqxmd.com/read/28182644/multiple-strains-probiotics-appear-to-be-the-most-effective-probiotics-in-the-prevention-of-necrotizing-enterocolitis-and-mortality-an-updated-meta-analysis
#12
Hung-Yang Chang, Jin-Hua Chen, Jui-Hsing Chang, Hung-Chih Lin, Chien-Yu Lin, Chun-Chih Peng
BACKGROUND: Some oral probiotics have been shown to prevent necrotizing enterocolitis (NEC) and decrease mortality effectively in preterm very low birth weight (PVLBW) infants. However, it is unclear whether a single probiotic or a mixture of probiotics is most effective for the prevention of NEC. OBJECTIVE: A meta-analysis was conducted by reviewing the most up to date literature to investigate whether multiple strains probiotics are more effective than a single strain in reducing NEC and death in PVLBW infants...
2017: PloS One
https://www.readbyqxmd.com/read/28133894/seven-cases-of-saccharomyces-fungaemia-related-to-use-of-probiotics
#13
Ujjwayini Roy, Laxman G Jessani, Shivaprakash M Rudramurthy, Ram Gopalakrishnan, Soma Dutta, Chandrashish Chakravarty, Joseph Jillwin, Arunaloke Chakrabarti
Probiotics are increasingly used in critically ill patients without enough safety data. The aim of the present study was to determine the association of probiotics with Saccharomyces cerevisiae fungaemia. Seven patients with S. cerevisiae fungaemia were reported at two hospitals in India between July 2014 and September 2015. Detailed clinical history of patients was recorded. Besides the seven patient isolates, three probiotics sachets used in those patients and five unrelated clinical isolates were used for association study by Fluorescent amplified fragment length polymorphism (FAFLP)...
June 2017: Mycoses
https://www.readbyqxmd.com/read/28126723/different-specificities-of-two-aldehyde-dehydrogenases-from-saccharomyces-cerevisiae-var-boulardii
#14
Suprama Datta, Uday S Annapore, David J Timson
Aldehyde dehydrogenases play crucial roles in the detoxification of exogenous and endogenous aldehydes by catalyzing their oxidation to carboxylic acid counterparts. This study reports characterization of two such isoenzymes from the yeast Saccharomyces cerevisiae var. boulardii (NCYC 3264), one mitochondrial (Ald4p) and one cytosolic (Ald6p). Both Ald4p and Ald6p were oligomeric in solution and demonstrated positive kinetic cooperativity towards aldehyde substrates. Wild-type Ald6p showed activity only with aliphatic aldehydes...
January 26, 2017: Bioscience Reports
https://www.readbyqxmd.com/read/28115360/saccharomyces-boulardii-administration-can-inhibit-the-formation-of-gastric-lymphoid-follicles-induced-by-helicobacter-suis-infection
#15
Lin Yang, Zi-Bin Tian, Ya-Nan Yu, Cui-Ping Zhang, Xiao-Yu Li, Tao Mao, Xue Jing, Wen-Jun Zhao, Xue-Li Ding, Ruo-Ming Yang, Shuai-Qing Zhang
Helicobacter suis has a greater tendency to induce gastric mucosa-associated lymphoid tissue lymphoma compared with other Helicobacter species in humans and animals. Saccharomyces boulardii has been established as an adjunct to H. pylori eradication treatment, but the effect of S. boulardii administration alone on Helicobacter infection remains unclear. Here, we found that S. boulardii administration effectively decreased the bacterial load of H. suis and inhibited the formation of lymphoid follicles in the stomach post-infection...
January 1, 2017: Pathogens and Disease
https://www.readbyqxmd.com/read/28073414/-protective-effect-of-saccharomyces-boulardii-against-intestinal-mucosal-barrier-injury-in-rats-with-nonalcoholic-fatty-liver-disease
#16
Y T Liu, Y Q Li, Y Z Wang
Objective: To investigate the protective effect of Saccharomyces boulardii against intestinal mucosal barrier injury in rats with nonalcoholic fatty liver disease (NAFLD). Methods: A total of 36 healthy male Sprague-Dawley rats with a mean body weight of 180±20 g were randomly divided into control group, model group, and treatment group, with 12 rats in each group, after adaptive feeding for 1 week. The rats in the control group were given basic feed, and those in the model group and treatment group were given high-fat feed...
December 20, 2016: Zhonghua Gan Zang Bing za Zhi, Zhonghua Ganzangbing Zazhi, Chinese Journal of Hepatology
https://www.readbyqxmd.com/read/28050843/evaluating-the-probiotic-and-therapeutic-potentials-of-saccharomyces-cerevisiae-strain-obs2-isolated-from-fermented-nectar-of-toddy-palm
#17
Banoth Srinivas, Ganapathiwar Swarupa Rani, Bhukya Kiran Kumar, Banoth Chandrasekhar, Kommalapati Vamsi Krishna, Tangutur Anjana Devi, Bhukya Bhima
The purpose of this study is to evaluate the probiotic characteristics of 15 yeast strains isolated from nectar of toddy palm. Initially, the collected samples were inoculated on yeast extract peptone dextrose agar plates and the colonies so obtained were culturally and morphologically characterized. Commercial probiotic yeast, Saccharomyces boulardii served as the control in these experiments. Of the 15 yeast strains, the isolates that were resistant to antibiotics and worked synergistically with other cultures were considered for further evaluation...
December 2017: AMB Express
https://www.readbyqxmd.com/read/28050461/role-of-saccharomyces-boulardii-in-reduction-of-neonatal-hyperbilirubinemia
#18
V Suganthi, A Gokul Das
INTRODUCTION: Probiotics are known to reduce the severity of hyperbilirubinemia. AIM: This study was done to evaluate the effect of probiotic on neonatal hyperbilirubinemia in term neonates. MATERIALS AND METHODS: A total of 181 healthy term neonates after birth were divided into a control group (n=95) and a treatment group (n=86) randomly and treated with placebo and probiotic (Saccharomyces boulardii) respectively. A total of two doses were given orally in the first two consecutive days...
November 2016: Journal of Clinical and Diagnostic Research: JCDR
https://www.readbyqxmd.com/read/28024866/saccharomyces-boulardii-probiotic-associated-fungemia-questioning-the-safety-of-this-preventive-probiotic-s-use
#19
Isabella W Martin, Rita Tonner, Julie Trivedi, Heather Miller, Richard Lee, Xinglun Liang, Leo Rotello, Elena Isenbergh, Jennifer Anderson, Trish Perl, Sean X Zhang
We report a case of fungemia in an immunocompetent patient after administration of probiotic containing Saccharomyces boulardii. We demonstrated the strain relatedness of the yeast from the probiotic capsule and the yeast causing fungal infection using genomic and proteomic typing methods. Our study questions the safety of this preventative biotherapy.
March 2017: Diagnostic Microbiology and Infectious Disease
https://www.readbyqxmd.com/read/28008823/saccharomyces-boulardii-improves-humoral-immune-response-to-dna-vaccines-against-leptospirosis
#20
Marcelle Moura Silveira, Fabricio Rochedo Conceição, Marcelo Mendonça, Gustavo Marçal Schmidt Garcia Moreira, Carlos Eduardo Pouey Da Cunha, Neida Lucia Conrad, Patrícia Diaz de Oliveira, Daiane Drawanz Hartwig, Priscila Marques Moura De Leon, Ângela Nunes Moreira
PURPOSE: Saccharomyces boulardii may improve the immune response by enhancing the production of anti-inflammatory cytokines, T-cell proliferation and dendritic cell activation. The immunomodulator effect of this probiotic has never been tested with DNA vaccines, which frequently induce low antibody titers. This study evaluated the capacity of Saccharomyces boulardii to improve the humoral and cellular immune responses using DNA vaccines coding for the leptospiral protein fragments LigAni and LigBrep...
February 2017: Journal of Medical Microbiology
keyword
keyword
67197
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"